Status:
RECRUITING
An Effectiveness Evaluation for Pathway to Healthy Aging (Path-HA) Care on Health Status of Older Adults
Lead Sponsor:
The University of Hong Kong
Conditions:
Ageing Well
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to provide a scientific evaluation on the effects of a protocol-driven Pathway to Healthy Aging (Path-HA) Program on promoting the health-related quality of life and...
Detailed Description
This assessor-blind, randomized controlled trial evaluates the effects of the Pathway to Healthy Aging Program, which is based on the WHO ICOPE model, on the promotion of the health-related quality of...
Eligibility Criteria
Inclusion
- 1\) aged 60 or above,
- 2\) with at least two risk factors of accelerating aging defined as including reduced physical functioning, malnutrition, depressed mood, loneliness, poor health perception, and presence of geriatric symptoms (e.g. insomnia, pain, etc), based on their health screening results,
- 3\) community-dwelling,
- 4\) communicable to engage in health education activity.
Exclusion
- 1\) any who is not at or at only one risk factor of accelerating aging,
- 2\) any who has problems in communicating with the research team.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06105723
Start Date
January 1 2024
End Date
March 31 2026
Last Update
December 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong
Hong Kong, Hong Kong